These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16871882)

  • 1. Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Germano IM; Uzzaman M; Benveniste RJ; Zaurova M; Keller G
    J Neurosurg; 2006 Jul; 105(1):88-95. PubMed ID: 16871882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
    Uzzaman M; Keller G; Germano IM
    J Neurosurg; 2007 Apr; 106(4):646-51. PubMed ID: 17432717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of TRAIL recombinant adenovirus in human malignant glioma cells.
    Kim KU; Seo SY; Heo KY; Yoo YH; Kim HJ; Lee HS; Choi SS; Hwang TH; Lee HJ
    J Korean Med Sci; 2005 Dec; 20(6):1046-52. PubMed ID: 16361820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
    Uzzaman M; Keller G; Germano IM
    Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell-derived astrocytes: a novel gene therapy vector for brain tumors.
    Uzzaman M; Benveniste RJ; Keller G; Germano IM
    Neurosurg Focus; 2005 Sep; 19(3):E6. PubMed ID: 16190605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
    Lee J; Hampl M; Albert P; Fine HA
    Neoplasia; 2002; 4(4):312-23. PubMed ID: 12082547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.
    Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.
    Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO
    Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
    Matsuzaki H; Schmied BM; Ulrich A; Standop J; Schneider MB; Batra SK; Picha KS; Pour PM
    Clin Cancer Res; 2001 Feb; 7(2):407-14. PubMed ID: 11234897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.
    Huang X; Lin T; Gu J; Zhang L; Roth JA; Liu J; Fang B
    Int J Oncol; 2003 Jun; 22(6):1241-5. PubMed ID: 12738989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharides-activated human astroglioma cells induce apoptotic death of T-lymphocytes via c-Jun N-terminal kinases-dependent up-regulation of TRAIL.
    Kwon D; Cheong JH; Lee JC; Kwon JH; Kim WK
    Neurosci Res; 2006 Apr; 54(4):338-43. PubMed ID: 16442178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.